Vimarsana
Biggest News Aggregation in the World

Perceptive Life Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Perceptive Life Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Perceptive Life Sciences Today - Breaking & Trending Today

This Legendary Billionaire Biotech Investor Has Remained A Mystery—Until Now - Vimarsana News

This Legendary Billionaire Biotech Investor Has Remained A Mystery—Until Now

In an exclusive excerpt from For Blood And Money, the untold story of Wayne Rothbaum and the worst trade of his life. But what cost him some $700 million turned out to be the boon for countless cancer patients.

Source: forbes.com
IPO Update: Acrivon Therapeutics Readies $100 Million IPO - Vimarsana News

IPO Update: Acrivon Therapeutics Readies $100 Million IPO

Acrivon Therapeutics has filed proposed terms for a $100 million U.S. IPO. Click here to read more about ACRV stock and about the IPO.

Acrivon Therapeutics (ACRV) Begins U.S. IPO Rollout - Vimarsana News

Acrivon Therapeutics (ACRV) Begins U.S. IPO Rollout

Acrivon Therapeutics has filed to raise $119 million in an IPO, although the final figure may differ. Click here to learn more about ACRV IPO.

Startup making digital therapeutic for pelvic floor disorders raises $17M - Vimarsana News

Startup making digital therapeutic for pelvic floor disorders raises $17M

MedCity News Startup making digital therapeutic for pelvic floor disorders raises $17M Renovia, a digital health startup that developed an app-based program for urinary incontinence, raised $17 million in funding. The company recently completed a clinical trial that it plans to share with insurance carriers as evidence of its efficacy.  Shares0 Women’s health startup Renovia raised $17 million to market its lead product, a digital therapeutic for pelvic floor disorders. Photo credit: Renovia Boston-based startup Renovia raised $17 million for its digital therapeutic, designed to help peo...